Items where authors include "Amin, A."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Critchlow, S. orcid.org/0000-0001-6862-765X, Bullement, A. orcid.org/0000-0001-7091-0972, Crabb, S. orcid.org/0000-0003-3521-9064 et al. (9 more authors) (2023) Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland. Future Oncology. ISSN 1479-6694

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Amro, I. orcid.org/0000-0001-7358-7963, Ali, A., Hassan, M.H.M.O. orcid.org/0000-0002-0920-3344 et al. (18 more authors) (2023) Design and field procedures for the clinical reappraisal of the Composite International Diagnostic Interview version 3.3 in Qatar's national mental health study. International Journal of Methods in Psychiatric Research. e1958. ISSN 1049-8931

Bullement, A. orcid.org/0000-0001-7091-0972, Willis, A., Amin, A. et al. (3 more authors) (2020) Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection. BMC Medical Research Methodology, 20. 103. ISSN 1471-2288

Bullement, A. orcid.org/0000-0001-7091-0972, Nathan, P., Willis, A. et al. (6 more authors) (2019) Cost effectiveness of Avelumab for metastatic Merkel cell carcinoma. PharmacoEconomics - Open, 3 (3). pp. 377-390. ISSN 2509-4262

Block, K.I., Gyllenhaal, C., Lowe, L. et al. (177 more authors) (2015) Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology, 35. S276-S304. ISSN 1044-579X

Proceedings Paper

Critchlow, S., Xiao, Y., Crabb, S. et al. (9 more authors) (2022) POSC4 Modeling health-related outcomes with avelumab as a first-line maintenance treatment following chemotherapy vs. best supportive care (BSC) for patients with locally advanced or metastatic urothelial cancer in the UK. In: Value in Health. Virtual ISPOR Europe 2021, 30 Nov - 03 Dec 2021, Virtual conference. Elsevier BV , S32-S33.

Bharmal, M., Amin, A., Stapelkamp, C. et al. (5 more authors) (2018) Cost-effectiveness (CE) of avelumab vs standard care (SC) for the treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC). In: Annals of Oncology. 43rd ESMO Congress (ESMO 2018), 19-23 Oct 2018, Munich, Germany. Elsevier , p. 461.

Bullement, A. orcid.org/0000-0001-7091-0972, Amin, A., Stapelkamp, C. et al. (5 more authors) (2018) Modelling overall survival in immunotherapy using parametric techniques : Avelumab in previously treated metastatic Merkel cell carcinoma. In: Value in Health. ISPOR 21st Annual European Meeting, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S11-S11.

Bullement, A. orcid.org/0000-0001-7091-0972, D'Angelo, S.P., Amin, A. et al. (5 more authors) (2018) Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab. In: Journal of Clinical Oncology. 2018 ASCO Annual Meeting, 01-05 Jun 2018, Chicago, IL, USA. American Society of Clinical Oncology .